Personalized risk reports may boost lung cancer screening and smoking cessation
NCT ID NCT05627674
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether giving smokers and former smokers a personalized risk report (based on clinical and genetic factors) helps doctors order lung cancer screening and helps patients follow through. About 915 participants will be randomly assigned to usual care or one of two versions of the risk feedback tool. The goal is to see if tailored information can increase prevention behaviors in primary care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
RiskProfile (personalized risk feedback tool)
What this could lead to
If successful, this could show that giving patients personalized risk information (including genetic factors) boosts lung cancer screening and smoking cessation in primary care.
What could go wrong
This is a behavioral study, not a drug trial. Results depend on how doctors and patients act, and may not apply to all clinics or populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMOKING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States